We are live on ! Find out more
PSTV icon

Plus Therapeutics
PSTV

6 hedge funds and large institutions have $1.28M invested in Plus Therapeutics in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

20% more funds holding

Funds holding: 5 → 6 (+1)

14% more capital invested

Capital invested by funds: $1.12M → $1.28M (+$160K)

0% less ownership

Funds ownership: 0% → 0% (-0%)

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
1
Calls
$13K
Puts
–
Net Calls
+$13K
Net Calls Change
+$13K

Top Buyers

Rank Fund Capital Flow
1
JG
Jefferies Group
New York
+$263K
2
VF
Virtu Financial
New York
+$65.7K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$52K
2
Macquarie Group
Macquarie Group
Australia
-$10K
3
Citadel Advisors
Citadel Advisors
Florida
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
1
Perkins Capital Management
Minnesota
$593K – – –
JG
2
Jefferies Group
New York
$214K +$263K +4 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$174K – – –
BlackRock
4
BlackRock
New York
$91K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$47K – – –
VF
6
Virtu Financial
New York
$41K +$65.7K +1 New
Creative Planning
7
Creative Planning
Kansas
$22K – – –
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
$18K – – –
Northern Trust
9
Northern Trust
Illinois
$16K – – –
Bank of New York Mellon
10
Bank of New York Mellon
New York
$14K – – –
IP
11
Intellectus Partners
California
$9K – – –
UBS Group
12
UBS Group
Switzerland
$8K – – –
William Blair & Company
13
William Blair & Company
Illinois
$7K – – –
HighTower Advisors
14
HighTower Advisors
Illinois
$5K – – –
California Public Employees Retirement System
15
California Public Employees Retirement System
California
$4K – – –
FPF
16
FNY Partners Fund
New York
$4K – – –
MCM
17
Marathon Capital Management
Maryland
$3K – – –
PCM
18
Princeton Capital Management
New Jersey
$2K – – –
LTFS
19
Ladenburg Thalmann Financial Services
Florida
$1K – – –
Morgan Stanley
20
Morgan Stanley
New York
$1K – – –
PMFA
21
Plante Moran Financial Advisors
Michigan
$1K – – –
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$1K – – –
FDCDDQ
23
Federation des caisses Desjardins du Quebec
Quebec, Canada
$38 – – –
Jane Street
24
Jane Street
New York
– -$52K -1 Closed
Citadel Advisors
25
Citadel Advisors
Florida
– -$6K – –
1
2

PSTV Hedge Fund Activity: Q1 2018 in Review

6 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q1 2018, worth a combined $1.28M — up 14% from $1.12M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new PSTV positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Jefferies Group, opening a new position worth an estimated $263K. The largest seller was Jane Street, exiting entirely with an estimated $52K sold.

  • 6 institutional investors held Plus Therapeutics (PSTV) as of Q1 2018, up from 5 in Q4 2017.
  • Funds reported $1.28M of Plus Therapeutics stock for Q1 2018, up 14% quarter-over-quarter.
  • 2 funds opened new Plus Therapeutics positions in Q1 2018 and 1 closed out, a net change of +1 holder.
  • The largest Plus Therapeutics buyer in Q1 2018 was Jefferies Group, an estimated $263K added.
  • The largest Plus Therapeutics seller in Q1 2018 was Jane Street, an estimated $52K sold.

Based on aggregated 13F filings for Q1 2018.